• Return to Headlines

Highest Price to Forward Sales in the Life Sciences Tools & Services Industry Detected in Shares of Accelerate Diagn (AXDX, ILMN, TECH, NEO, WAT)

By Shiri Gupta

Below are the three companies in the Life Sciences Tools & Services industry with the highest price to forward sales ratios. The ratio shows how much Wall Street values every dollar of the company's future sales and is useful in comparing comparable companies. Generally the lower the ratio, the more attractive the investment.

Accelerate Diagn ranks highest with a a price to forward sales ratio of 15.44. Illumina Inc is next with a a price to forward sales ratio of 12.17. Bio-Techne Corp ranks third highest with a a price to forward sales ratio of 11.24.

Neogenomics Inc follows with a a price to forward sales ratio of 8.92, and Waters Corp rounds out the top five with a a price to forward sales ratio of 6.61.

SmarTrend is tracking the current trend status for Accelerate Diagn and will alert subscribers who have AXDX in their portfolio or watchlist when shares have changed trend direction.

Keywords: highest price to forward sales accelerate diagn illumina inc bio-techne corp neogenomics inc waters corp

Ticker(s): AXDX ILMN TECH NEO WAT